Pomegranate compound with anti-aging effects passes human trial

pomegranate
Credit: CC0 Public Domain

Urolithin A, a metabolite of biomolecules found in pomegranates and other fruits, could help slow certain aging processes. EPFL spin-off Amazentis, in conjunction with EPFL and the Swiss Institute of Bioinformatics, has published a paper in the journal Nature Metabolism outlining the results of their clinical trial.

It is a fact of life that skeletal muscles begin to lose strength and mass once a person reaches the age of 50. A recent clinical trial involving two EPFL entities—spin-off Amazentis and the Laboratory of Integrative Systems Physiology (LISP) – showed that urolithin A, a compound derived from biomolecules found in fruits such as pomegranates, could slow down this process by improving the functioning of mitochondria—the cells' powerhouses. A joint paper presenting the results of the trial, published today in Nature Metabolism, also demonstrates that ingesting the compound poses no risk to human health.

Slowing mitochondrial aging

The claim that healthy eating is the key to longer life might seem too convenient—but it is now further backed by scientific evidence. Pomegranate, a fruit prized by many civilizations for its health benefits, contains ellagitannins. When ingested, these molecules are converted into a compound called urolithin A (UA) in the human gut. The researchers found that UA can slow down the mitochondrial aging process. The catch is that not everyone produces UA naturally.

To get around that problem, and to make sure all participants received an equal dose, the team synthesized the compound. Some 60 elderly people, all sedentary yet in good health, took a single dose of between 250 and 2,000 mg of UA. The researchers observed no side effects when compared with the control group, who were given a placebo. The participants were then split into four groups, each receiving a placebo, or a 250, 500 or 1,000 mg daily dose of UA for 28 days. Again, no adverse health impacts were found, even after prolonged ingestion. The team then assessed the efficacy of UA by looking at cellular and mitochondrial health in the participants' blood and muscle tissue. The results were compelling: UA stimulates mitochondrial biogenesis—the process by which cells increase mitochondrial mass—in the same way as regular exercise.

UA is the only known compound that re-establishes cells' ability to recycle defective mitochondria. In young people, this process happens naturally. But as we age, our body starts to lose its power to clean up dysfunctional , causing sarcopenia (loss of mass) and the weakening of other tissues. The team focused on slowing, or even reversing, this natural effect of aging.

The paper, published today, also confirms that the compound is safe to eat. Amazentis, based at EPFL's Innovation Park, hopes to harness the promising results to quickly bring the product to market. "These latest findings, which build on previous preclinical trials, really crystallize how UA could be a game-changer for human health," says Johan Auwerx, a professor at LISP, the EPFL lab involved in the trial. An article published in 2016 showed that the lifespan of nematode worms exposed to UA increased by 45 percent—from around 20 to 30 days—when compared with the control group. Likewise, older mice showed 40 percent better endurance while running after two weeks of treatment. The compound may thus have even more secrets to reveal about its benefits for human health.


Explore further

Pomegranate finally reveals its powerful anti-aging secret

More information: Pénélope A. Andreux et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans, Nature Metabolism (2019). DOI: 10.1038/s42255-019-0073-4
Journal information: Nature Metabolism

Citation: Pomegranate compound with anti-aging effects passes human trial (2019, June 17) retrieved 23 July 2019 from https://medicalxpress.com/news/2019-06-pomegranate-compound-anti-aging-effects-human.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7256 shares

Feedback to editors

User comments

Jun 24, 2019
Soon, affluent folks will bask in another advantage over those afflicted by poverty.
Ah, science for the good of man.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more